Latest news with #LAM
Business Wire
5 days ago
- Business
- Business Wire
Lazard Asset Management Appoints Eric Van Nostrand Global Head of Markets and Chief Economist
NEW YORK--(BUSINESS WIRE)--Lazard Asset Management (LAM) today announced that Eric Van Nostrand has joined the firm as Global Head of Markets and Chief Economist. In this newly created role reporting to LAM CEO Evan Russo, Mr. Van Nostrand will work across the firm's investment and research teams, bringing additional macro insights and market perspectives to our investment decisions. As a member of the executive leadership team for Lazard's Asset Management business, he will lead economic and market analysis for the firm and its clients, including oversight and development of investment content. "Financial markets around the world are becoming increasingly complex, with global economic volatility and policy decisions profoundly influencing market dynamics and investment outcomes," said Evan Russo, CEO of Lazard Asset Management. 'Eric joins the firm at a time where actionable economic analysis and macro insights are more critical to investment success. Lazard is renowned for its deep research and investment acumen, and Eric's background and experience will further enhance our capabilities to deliver world-class investment solutions and insights for our clients.' Mr. Van Nostrand most recently served as Assistant Secretary of the Treasury for Economic Policy, serving as Chief Economist at the US Treasury Department under Secretary Janet Yellen. Eric received the Alexander Hamilton Award, Treasury's highest honor. Prior to his government role, Mr. Van Nostrand was a portfolio manager and Managing Director at BlackRock, where he managed systematic equity funds and served as Head of Research for Multi-Asset Strategies. He earned undergraduate degrees from the University of Pennsylvania and holds a JD from Yale Law School. 'I'm excited to join Lazard Asset Management and help our investment teams deliver market-leading investment performance to our clients,' said Mr. Van Nostrand. 'Lazard has a distinguished reputation and proven track record for generating alpha, grounded in rigorous investment research and analysis. I am looking forward to contributing to those efforts to help our clients achieve their investment goals.' About Lazard Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit and follow Lazard on LinkedIn. Lazard Asset Management, a subsidiary of Lazard, Inc. (NYSE: LAZ), offers a range of equity, fixed income, and alternative investment products worldwide. As of April 30, 2025, Lazard's asset management businesses managed approximately $231 billion of client assets. For more information about LAM, please visit LAZ-AM
Daily Mirror
25-05-2025
- Health
- Daily Mirror
Woman, 24, diagnosed with life-changing condition after collapsing in gym
Harriet Davidson was diagnosed with lymphangioleiomyomatosis (LAM) in 2019 after suffering a collapsed lung while at the gym - she was told her lung function will decline rapidly A woman diagnosed with a rare and incurable lung disease at the tender age of 24 is seizing the day despite her challenging condition. Harriet Davidson smashed expectations last weekend by completing the 10km course at the Great Bristol Run, an achievement that seemed out of reach a few years back when she had to endure major lung surgery. Back in April 2019, Harriet was struck by a sudden lung collapse while working out at the gym, with no apparent cause. After a fortnight in hospital, it wasn't until a CT scan that doctors spotted hundreds of cysts on her lungs. She was then diagnosed with lymphangioleiomyomatosis (LAM), a rare condition that targets the lungs and kidneys and mainly affects women. Now at 30, she's spent months training to finish the 10km race, all the while raising awareness and funds for the charity that's been her rock during her health ordeal. Harriet, from Bristol, said: "This disease has truly changed my life. I was told my lung function will decline rapidly, and that I may have a short life and might even require a lung transplant. Fast forward six years, I have had the best fitness I may have ever had. "I have been training so hard for the Bristol 10km, taking up running, something I thought I would never enjoy. Playing football again, cycling, and living life to the full." While battling her own health struggles, Harriet has stepped up as a key advocate for those dealing with LAM. She heaps praise on the charity LAM Action for giving her access to Rapamycin, a medication she believes could be life-saving. Gaining international attention, she even took to the stage in Chicago to shine a light on the illness, reports Bristol Live. Harriet didn't know about her condition when she was treated for a benign kidney tumour back in 2013; it's a rare disease, impacting roughly 350 women across the UK. With a finishing time of 1:05:08, Harriet has drummed up over £6,000 for LAM Action. Alongside her at the starting line were about 50 mates, loved ones, and well-wishers who gathered on Sunday, May 11. This event meant the world to Harriet not just due to her health saga but also as it represented the biggest turnout for LAM Action yet, all sporting branded T-shirts to champion the cause. Harriet expressed her heartfelt gratitude: "Without their support, I would never have been offered the medication Rapamycin, which could potentially save my life. "I will forever be grateful for the contributions of scientists, clinicians and charities who have allowed me to be in the position that I am now." Dedicated to aiding women and families grappling with the condition, LAM Action pushes for improved treatment options and rigorous research. Harriet expressed her commitment, saying: "I endeavour to support other women like me, especially for those who haven't been as lucky as me, who have to have a lung transplant, and their families, and to provide the continued support for patients coming to terms with an incurable disease."
Time of India
21-05-2025
- Science
- Time of India
Glitch-hit NVS-02 can provide services only for 2-3 hours per day
BENGALURU: Even as the failure analysis committee (FAC) set up to look into the May 18 PSLV failure prepares for its first formal meeting, details about the defective valve that affected India's NV-02 navigation satellite , launched on Jan 29, have emerged, confirming that the satellite is only partially operational. Tired of too many ads? go ad free now In an official response to queries under right to information, has conceded that NVS-02's current orbital parameters — approximately 190km perigee (closest point to Earth) and 37,000km apogee (farthest point to Earth) — allow for only a few hours of usable Positioning, Navigation and Timing (PNT) service daily. 'At present, with the given orbital parameters of NVS-02, it is estimated to provide PNT service for an average duration of 2 to 3 hours per day. But this calls for user receiver modifications and firmware updates. Technical feasibility of the same is being worked out,' Isro's response reads. Isro's GSLV-F15 that lifted off with the NVS-02 at 6.23am on Jan 29 had placed the satellite which is part of India's NavIC constellation, in a geosynchronous transfer orbit (GTO) around 19 minutes later. Just a few hours later, Isro had detected a glitch in the valve that was to supply oxidiser to the liquid apogee motor (LAM). No exact reason Without oxidiser, Isro was unable to fire LAM, perform orbit corrections and take the satellite to the intended final orbit. The exact reason for the failure could not be ascertained, the response reads, noting that no single point failure was responsible. Test results confirmed that the issue was not related to power disconnection. Despite the reduced service window, Isro maintains that the accuracy of the PNT signal from NVS-02 will be 'usable'. Tired of too many ads? go ad free now The NVS-02, part of India's NavIC constellation, carries one indigenous Rubdium Frequency Standard (RAFS) and three foreign RAFS, which serve as timing sources critical to navigation accuracy. While Isro maintains that the Indian-made RAFS unit is performing comparably to their foreign counterparts, it declined to disclose technical information about the same, citing national scientific interest. PSLV failure Meanwhile, the FAC setup to investigate the cause of failure of the PSLV whose third stage (PS3) failed on May 18, was scheduled to meet for the first time on May 21. Isro chairman V Narayanan told TOI: 'I have conducted the six meetings so far, including four on the day of the launch. We have to enable the FAC to conduct its meeting.' While Isro has officially said that there was a drop in chamber pressure of the third stage (PS3) motor case, it is yet to conclude on what may have caused the pressure to dip. Sources had indicated to TOI, as reported in its May 19 edition, that reasons that may have caused the drop in pressure could be: depletion of internal insulation, which affects the fuel burn, or a defective nozzle. Narayanan, however, said: 'I don't want to preempt anything at this moment and all I can say is that it is connected to the third stage.' He said that the FAC headed by M Annamalai will investigate the matter. Annamalai is a former Isro scientist who has served as director, Satish Dhawan Space Centre (SDSC) and has earlier been part of multiple FACs.
Associated Press
01-05-2025
- Health
- Associated Press
Lupus Research Alliance Takes Action for Lupus Awareness Month: Striving for a World Free of Lupus
NEW YORK, May 1, 2025 /PRNewswire/ -- This May, the Lupus Research Alliance (LRA), the largest non-governmental private funder of lupus research, will shine a spotlight on lupus awareness and action as Lupus Awareness Month (LAM) kicks off. With a mission to educate, inspire, and connect, the LRA will lead efforts to raise awareness about lupus, empower individuals to take action, and unite the community. Lupus is a complex and often misunderstood autoimmune disease that impacts millions of people worldwide. In lupus, the immune system triggers attacks on the body's own cells, leading to inflammation and damage of vital organs such as the kidneys, brain, heart, lungs, and skin. Despite its widespread impact, the disease remains under-recognized. That's why this year's theme, 'Striving for a World Free of Lupus,' is a call to action for everyone to contribute in powerful ways to help eradicate lupus. Tremendous strides are well underway, but much work remains to be done to deliver much-needed individualized treatment options and ultimately, one day a cure. 'A world free of lupus is not just a vision — it's a goal we are working toward together,' said Albert T. Roy, President and CEO of the Lupus Research Alliance. 'Through scientific innovation and collaboration, we can accelerate progress and achieve meaningful impact. Lupus Awareness Month is our opportunity to amplify this mission, inspire action, and engage the lupus community. Accelerating Lupus Research: Partnering to Broaden Awareness Ali Vanderloop, who has lupus, and her husband Ty Majeski, 2024 NASCAR Truck Series Champion, are teaming up with ThorSport Racing and the LRA to launch a month-long campaign dedicated to raising awareness and funds for lupus research. The Accelerating Lupus Research initiative will get into full gear at the Texas Motor Speedway during the NASCAR Truck Series race on May 2. Throughout the month, Ty will wear custom-designed race shoes representing the LRA and the fight against lupus. The shoes will later be auctioned off, with proceeds benefiting LRA's efforts to find a cure. Educating About Lupus Throughout the month, the experiences of people living with lupus will be shared on the LRA digital platforms. The organization will share resources to raise awareness of the disease and the challenges it poses, featuring stories of accomplishments and opportunities that help achieve the ultimate goal – a world free of lupus. Everyone is encouraged to take part in this movement and let their voices be heard by using the new LRA Lupus Awareness Month Social Media Toolkit. The toolkit offers sample posts, images, and content that can be easily shared to raise awareness and show support. Special emphasis is placed on World Lupus Day (May 10), which brings global attention to the need for continued research and funding. The LRA is also excited to invite lupus supporters to participate in the Walk with Us to Cure Lupus events in New Jersey (May 17) and Michigan (June 14). These family-friendly events are designed to raise awareness, foster community connections, and fundraise for lupus research. Exploring New Frontiers in Lupus Treatment In a major educational effort, the LRA will host a virtual webinar May 1 in collaboration with Lupus Therapeutics, the clinical affiliate of the LRA. This session will focus specifically on T cell engagers, an emerging cell therapy. Driving Innovation: Scientific Collaboration The LRA is also facilitating important scientific discussions to push the boundaries of lupus research. This includes sponsoring a key session at the 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025), where leading researchers will share groundbreaking findings and collaborate on new strategies for combating lupus. Advocating for Change: On Capitol Hill The LRA is amplifying its advocacy efforts with a briefing at the U.S. Capitol to engage Congress on key issues related to lupus and public health policy. This briefing will underscore the need for increased investments in lupus research and biomedical advancements, laying the foundation for future breakthroughs in treatment and care. About Lupus Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. In lupus, the immune system, meant to defend against infections, produces autoantibodies that mistake the body's own cells as foreign, causing other immune cells to attack organs such as the kidneys, brain, heart, lungs and skin, as well as blood and joints. Ninety percent of people with lupus are women, most often diagnosed between the ages of 15-45. Black, Latinx, Indigenous, Asian and Pacific Islander people are disproportionately affected by lupus and more likely to experience severe lupus symptoms. About the Lupus Research Alliance The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering diverse scientific talent, and driving discovery toward better diagnostics, improved treatments and, ultimately a cure for lupus. Because the Lupus Research Alliance's Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs. For more information or to donate to lupus research, visit the LRA at and on social media at: X, Facebook, LinkedIn, and Instagram. View original content to download multimedia: SOURCE Lupus Research Alliance
